Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease
ConditionCopd
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCardenal Herrera University
About this trial
The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).
Eligibility criteria
Qualifiers
COPD;
Forced expiratory volume in the first second (FEV1) < 80%;
FEV1/Forced vital capacity (FVC) < 70%;
Maximal inspiratory pressure (MIP) < 70%.
Disqualifiers
Recent (6 months) spine or abdominal surgery;
Allergic status of any kind;
systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
neuromuscular or neurological injuries;
Trial design
Treatments tested in this trial
- Experimental-Myofascial + Respiratory rehabilitation
- Sham Myofascial + Respiratory rehabilitation
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov